这是一篇来自已证抗体库的有关
人类 DR4的综述,是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DR4 抗体。
DR4 同义词: APO2; CD261; DR4; TRAILR-1; TRAILR1
BioLegend
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(BioLegend, DJR1)被用于被用于流式细胞仪在人类样本上 (图 s2g). Cell Death Dis (2019) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(Biolegend, 307206)被用于被用于流式细胞仪在人类样本上 (图 1b, 1e). Front Immunol (2019) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(Biolegend, 307207)被用于被用于流式细胞仪在人类样本上 (图 s4d). Cell (2016) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(BioLegen d, 307206)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(BioLegend, 307205)被用于被用于流式细胞仪在人类样本上 (图 4). PLoS ONE (2015) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(BioLegend, 307201)被用于被用于免疫印迹在人类样本上浓度为1:2000. PLoS ONE (2014) ncbi |
小鼠 单克隆(DJR1) | | BioLegend DR4抗体(Biolegend, DJR1)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi |
赛默飞世尔
小鼠 单克隆(DJR1) | | 赛默飞世尔 DR4抗体(eBioscience, 12-6644-41)被用于被用于流式细胞仪在人类样本上 (图 4c). Cell Death Differ (2019) ncbi |
小鼠 单克隆(DJR1) | | 赛默飞世尔 DR4抗体(eBioscience, DJR1)被用于被用于流式细胞仪在人类样本上 (图 s2). BMC Biotechnol (2016) ncbi |
小鼠 单克隆(DJR1) | | 赛默飞世尔 DR4抗体(eBioscience, DJR1)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2013) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 1:400; 图 1b
| 艾博抗(上海)贸易有限公司 DR4抗体(Abcam, ab8414)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 (图 1b). PLoS ONE (2020) ncbi |
domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 1:200; 图 1b
| 艾博抗(上海)贸易有限公司 DR4抗体(Abcam, ab8416)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1b). PLoS ONE (2020) ncbi |
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司 DR4抗体(Abcam, ab8414)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5g). Mol Cancer Res (2017) ncbi |
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司 DR4抗体(Abcam, ab8416)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5g). Mol Cancer Res (2017) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(DR4.1) | | 圣克鲁斯生物技术 DR4抗体(Santa Cruz, sc-32255)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncotarget (2016) ncbi |
小鼠 单克隆(B-9) | | 圣克鲁斯生物技术 DR4抗体(Santa, B9)被用于被用于免疫细胞化学在人类样本上浓度为1:500. J Biol Chem (2011) ncbi |
Enzo Life Sciences
小鼠 单克隆(HS101) | | Enzo Life Sciences DR4抗体(Enzo, ALX-804-297F-T100)被用于被用于流式细胞仪在人类样本上 (图 4). Oncotarget (2016) ncbi |
安迪生物R&D
小鼠 单克隆(69036) | | 安迪生物R&D DR4抗体(R&D Systems, FAB347P)被用于被用于流式细胞仪在人类样本上 (图 5h). Mol Cancer Res (2017) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D9S1R) | | 赛信通(上海)生物试剂有限公司 DR4抗体(CST, 42533)被用于被用于免疫印迹在人类样本上 (图 2a). Cell Death Dis (2020) ncbi |
domestic rabbit 单克隆(D9S1R) | | 赛信通(上海)生物试剂有限公司 DR4抗体(CST, 42533)被用于被用于免疫印迹在人类样本上 (图 s4f). Cell Death Differ (2019) ncbi |
domestic rabbit 单克隆(D9S1R) | | 赛信通(上海)生物试剂有限公司 DR4抗体(Cell Signaling Technology, D9S1R)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2017) ncbi |
domestic rabbit 单克隆(D9S1R) | - 免疫印迹基因敲除验证; 人类; 1:1000; 图 9e
| 赛信通(上海)生物试剂有限公司 DR4抗体(Cell Signaling, D9S1R)被用于被用于免疫印迹基因敲除验证在人类样本上浓度为1:1000 (图 9e). Mol Cell Biol (2017) ncbi |
domestic rabbit 单克隆(D9S1R) | | 赛信通(上海)生物试剂有限公司 DR4抗体(Cell Signaling, 42533)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Biochem Cell Biol (2017) ncbi |
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(2.7A6A3) | | 贝克曼库尔特实验系统(苏州)有限公司 DR4抗体(BD Biosciences, IM2088U)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Biol Ther (2015) ncbi |
小鼠 单克隆(2.7A6A3) | | 贝克曼库尔特实验系统(苏州)有限公司 DR4抗体(Immunotech, 2.7A6A3)被用于被用于流式细胞仪在人类样本上 (表 1). J Transl Med (2014) ncbi |
小鼠 单克隆(2.7A6A3) | | 贝克曼库尔特实验系统(苏州)有限公司 DR4抗体(Beckman Coulter, IM2088U)被用于被用于流式细胞仪在人类样本上. Cell Death Dis (2014) ncbi |
ProSci
domestic rabbit 多克隆 | | ProSci DR4抗体(ProSci, 1139)被用于被用于免疫印迹在人类样本上 (图 2a). EMBO J (2017) ncbi |
Ding B, Yuan F, Damle P, Litovchick L, Drapkin R, Grossman S. CtBP determines ovarian cancer cell fate through repression of death receptors. Cell Death Dis. 2020;11:286
pubmed 出版商
Jun B, Lee W, Jang J, Jeong S, Chang Y, Lee S,
et al. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLoS ONE. 2020;15:e0227440
pubmed 出版商
Chollat Namy M, Ben Safta Saadoun T, Haferssas D, Meurice G, Chouaib S, Thiery J. The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell Death Dis. 2019;10:695
pubmed 出版商
Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S,
et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951
pubmed 出版商
Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J,
et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155
pubmed 出版商
Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735
pubmed 出版商
Lafont E, Kantari Mimoun C, Dráber P, De Miguel D, Hartwig T, Reichert M,
et al. The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death. EMBO J. 2017;36:1147-1166
pubmed 出版商
Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D,
et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37:
pubmed 出版商
Dimberg L, Towers C, Behbakht K, Hotz T, Kim J, Fosmire S,
et al. A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance. Mol Cancer Res. 2017;15:382-394
pubmed 出版商
Park S, Jwa E, Shin S, Ju E, Park I, Pak J,
et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int J Biochem Cell Biol. 2017;83:47-55
pubmed 出版商
Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J,
et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16
pubmed 出版商
Wang Z, Yu B, Wang B, Yan J, Feng X, Wang Z,
et al. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route. Oncotarget. 2016;7:47287-47301
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Liesche C, Venkatraman L, Aschenbrenner S, Grosse S, Grimm D, Eils R,
et al. Death receptor-based enrichment of Cas9-expressing cells. BMC Biotechnol. 2016;16:17
pubmed 出版商
De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S,
et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90
pubmed 出版商
Braun F, Mathur R, Sehgal L, Wilkie Grantham R, Chandra J, Berkova Z,
et al. Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis. PLoS ONE. 2015;10:e0117994
pubmed 出版商
Gomez Bougie P, Halliez M, Maïga S, Godon C, Kervoëlen C, Pellat Deceunynck C,
et al. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer Biol Ther. 2015;16:60-5
pubmed 出版商
Su Y, Cheng T, Chen C, Chang W, Tsai N, Kung C,
et al. Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic Lupus erythematosus. J Transl Med. 2014;12:303
pubmed 出版商
Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487
pubmed 出版商
Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M,
et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94
pubmed 出版商
Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M,
et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043
pubmed 出版商
Linderoth E, Pilia G, Mahajan N, Ferby I. Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death. J Biol Chem. 2013;288:32922-31
pubmed 出版商
Cazanave S, Mott J, Bronk S, Werneburg N, Fingas C, Meng X,
et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem. 2011;286:39336-48
pubmed 出版商